Skip to main content
International Journal of Pharmaceutical Investigation logoLink to International Journal of Pharmaceutical Investigation
letter
. 2012 Oct-Dec;2(4):218. doi: 10.4103/2230-973X.107008

Delivery of nutraceuticals using nanotechnology

Viroj Wiwanitkit 1,
PMCID: PMC3618639  PMID: 23580939

Sir,

The editorial on delivery of nutraceuticals using nanotechnology is very interesting.[1] As noted, successful formulation of new nanosubstance is the hope. However, the effectiveness and safety is still the consideration.[1,2] The concern is further testing of the new nano-product. A good testing system is needed. Generally in vitro experiment might be convenient but it cannot answer the question. There are many concerns of the nano-products. The in vivo stability of the new product must be studied. Indeed, the nanosubstance is usually highly sensitive and aggregation can easily occur. As a result, changes in the physical and biochemical properties can be expected. On the other hand, when a biochemical substance is changed to nano-level, there must be changes in its physical and biochemical properties. These considerations are recommended for nano-nutraceutical products: a) confirmation of their nutraceutical properties at nano-level, b) confirmation of good production process, c) confirmation of the quality and stability of the product, d) good product test to confirm efficacy and safety, and e) long-term follow-up to study the unwanted adverse effect of the product.

REFERENCES


Articles from International Journal of Pharmaceutical Investigation are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES